NO305170B1 - Morfolinderivat - Google Patents

Morfolinderivat

Info

Publication number
NO305170B1
NO305170B1 NO953118A NO953118A NO305170B1 NO 305170 B1 NO305170 B1 NO 305170B1 NO 953118 A NO953118 A NO 953118A NO 953118 A NO953118 A NO 953118A NO 305170 B1 NO305170 B1 NO 305170B1
Authority
NO
Norway
Prior art keywords
morpholine
reincorporation
anxiety
depression
chem
Prior art date
Application number
NO953118A
Other languages
English (en)
Norwegian (no)
Other versions
NO953118L (no
NO953118D0 (no
Inventor
Mitsuo Fujii
Takayuki Suzuki
Satoshi Hayashibe
Shin-Ichi Tsukamoto
Shin-Ichi Yatsugi
Tokio Yamaguchi
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO953118D0 publication Critical patent/NO953118D0/no
Publication of NO953118L publication Critical patent/NO953118L/no
Publication of NO305170B1 publication Critical patent/NO305170B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
NO953118A 1993-02-10 1995-08-09 Morfolinderivat NO305170B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4569193 1993-02-10
JP24014793 1993-09-27
PCT/JP1994/000186 WO1994018182A1 (en) 1993-02-10 1994-02-08 Morpholine derivative

Publications (3)

Publication Number Publication Date
NO953118D0 NO953118D0 (no) 1995-08-09
NO953118L NO953118L (no) 1995-10-10
NO305170B1 true NO305170B1 (no) 1999-04-12

Family

ID=26385743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953118A NO305170B1 (no) 1993-02-10 1995-08-09 Morfolinderivat

Country Status (18)

Country Link
US (1) US5521180A (pt)
EP (1) EP0684237B1 (pt)
KR (1) KR100302819B1 (pt)
CN (1) CN1042028C (pt)
AT (1) ATE187448T1 (pt)
AU (1) AU670675B2 (pt)
CA (1) CA2155183A1 (pt)
DE (1) DE69422021T2 (pt)
DK (1) DK0684237T3 (pt)
ES (1) ES2142397T3 (pt)
FI (1) FI953793A0 (pt)
GR (1) GR3032816T3 (pt)
HU (1) HU220383B (pt)
NO (1) NO305170B1 (pt)
PT (1) PT684237E (pt)
TW (1) TW397829B (pt)
UA (1) UA41350C2 (pt)
WO (1) WO1994018182A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6337328B1 (en) * 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
AU9087301A (en) * 2000-09-11 2002-03-26 Sepracor Inc Ligands for monoamine receptors and transporters, and methods of use thereof
US7294637B2 (en) * 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
JP2005034165A (ja) * 2002-06-26 2005-02-10 Mu-Hyun Cho マット一体型のストーンベッド
EP1767217A1 (en) * 2004-07-14 2007-03-28 Astellas Pharma Inc. Agent for promoting the recovery from dysfunction after the onset of central neurological disease
TW200846003A (en) * 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
TW200846002A (en) 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
EP2291181B9 (en) 2008-04-18 2013-09-11 University College Dublin National University Of Ireland, Dublin Captodiamine for the treatment of depression symptoms
KR101165996B1 (ko) 2010-04-23 2012-07-18 주식회사 녹십자 프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives
JPS5283773A (en) * 1976-01-01 1977-07-12 Yamanouchi Pharmaceut Co Ltd Novel indene derivative
JPS52111580A (en) * 1976-03-15 1977-09-19 Yamanouchi Pharmaceut Co Ltd Novel indene derivatives and salts thereof
JPS55113717A (en) * 1979-02-24 1980-09-02 Yamanouchi Pharmaceut Co Ltd Antidepressive drug
JPS61145119A (ja) * 1984-12-19 1986-07-02 Yamanouchi Pharmaceut Co Ltd 脳障害による精神症状の改善，治療剤
AU5136385A (en) * 1984-12-20 1986-07-17 Medicament P.F 2-arylalkyloxymethyl-morpholine derivatives
GB2177085A (en) * 1985-06-18 1987-01-14 Ici Plc Fungicidal compounds and compositions

Also Published As

Publication number Publication date
NO953118L (no) 1995-10-10
DK0684237T3 (da) 2000-05-08
KR100302819B1 (ko) 2001-11-22
CN1117729A (zh) 1996-02-28
ATE187448T1 (de) 1999-12-15
AU5980094A (en) 1994-08-29
EP0684237A4 (en) 1996-02-14
HU220383B (hu) 2002-01-28
EP0684237B1 (en) 1999-12-08
DE69422021T2 (de) 2000-07-13
WO1994018182A1 (en) 1994-08-18
NO953118D0 (no) 1995-08-09
DE69422021D1 (en) 2000-01-13
US5521180A (en) 1996-05-28
HUT72674A (en) 1996-05-28
FI953793A (fi) 1995-08-10
EP0684237A1 (en) 1995-11-29
TW397829B (en) 2000-07-11
UA41350C2 (uk) 2001-09-17
PT684237E (pt) 2000-04-28
HU9502359D0 (en) 1995-10-30
AU670675B2 (en) 1996-07-25
FI953793A0 (fi) 1995-08-10
CN1042028C (zh) 1999-02-10
GR3032816T3 (en) 2000-06-30
ES2142397T3 (es) 2000-04-16
CA2155183A1 (en) 1994-08-18

Similar Documents

Publication Publication Date Title
IS6275A (is) Heteróhringa efnasambönd og notkun þeirra sem mótlyf efnaskiptaglútamatviðtaka
DE68924681D1 (de) Heterocyclische Biphosphonsäurederivate.
DK0870768T3 (da) Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler
NO308248B1 (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
EP1260510A4 (en) FLUORESCENT PROBES FOR THE QUANTIFICATION OF ZINC
DK0862562T3 (da) Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler
NO985518L (no) Morfinanderivater og medisinsk anvendelse derav
ATE237612T1 (de) Benzofuranderivate
NO934536D0 (no) Fenoksy- og fenoksyalkyl-pepiridiner som antivirale midler
DK0684237T3 (da) Morpholinderivater
ATE177096T1 (de) 4-substituierte 1,2,4-triazolderivate
NO20000737L (no) Tetrahydro <gamma>-karboliner
TR199802552T2 (xx) 5-HT-2C Resept�r kar��tlar� olarak faydal� indolin t�revleri.
DE69430618D1 (de) Cephemverbindungen
ATE219486T1 (de) Trizyklische indol-2-carbonsäure derivate als selektive nmda rezeptor antagonisten
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
DE69319900D1 (de) N,n'-disubstituierte amidderivate
DK0782574T3 (da) Bicycliske carboxiamider som 5-HT1A-receptorligander
TH36308A (th) อนุพันธ์ n-เบนซิลาโซเลียม

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees